2Xideas AG Sells 96,740 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

2Xideas AG lowered its position in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN) by 38.6% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 153,897 shares of the company’s stock after selling 96,740 shares during the period. 2Xideas AG’s holdings in Ryan Specialty were worth $9,874,000 at the end of the most recent reporting period.

Several other large investors have also recently modified their holdings of RYAN. Sanctuary Advisors LLC grew its position in Ryan Specialty by 1.2% in the 4th quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company’s stock valued at $1,045,000 after purchasing an additional 188 shares during the period. State of Alaska Department of Revenue grew its holdings in Ryan Specialty by 1.6% during the fourth quarter. State of Alaska Department of Revenue now owns 12,130 shares of the company’s stock valued at $778,000 after purchasing an additional 190 shares during the period. CIBC Asset Management Inc raised its stake in shares of Ryan Specialty by 5.6% in the fourth quarter. CIBC Asset Management Inc now owns 3,674 shares of the company’s stock valued at $236,000 after buying an additional 196 shares during the period. Exchange Traded Concepts LLC boosted its position in Ryan Specialty by 2.6% during the fourth quarter. Exchange Traded Concepts LLC now owns 11,760 shares of the company’s stock worth $755,000 after purchasing an additional 295 shares during the period. Finally, UMB Bank n.a. grew its stake in Ryan Specialty by 5.7% in the 4th quarter. UMB Bank n.a. now owns 5,522 shares of the company’s stock valued at $354,000 after buying an additional 298 shares in the last quarter. Institutional investors own 84.82% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on the company. Wells Fargo & Company lifted their target price on Ryan Specialty from $64.00 to $69.00 and gave the company an “equal weight” rating in a report on Friday, February 21st. Keefe, Bruyette & Woods reduced their price objective on Ryan Specialty from $77.00 to $76.00 and set an “outperform” rating on the stock in a research report on Friday, February 21st. Royal Bank of Canada lowered their price target on shares of Ryan Specialty from $73.00 to $72.00 and set a “sector perform” rating for the company in a research note on Friday, February 21st. Finally, UBS Group increased their price objective on Ryan Specialty from $82.00 to $84.00 and gave the company a “buy” rating in a research note on Wednesday, February 26th. One analyst has rated the stock with a sell rating, six have given a hold rating and six have given a buy rating to the company’s stock. According to MarketBeat, Ryan Specialty presently has an average rating of “Hold” and a consensus price target of $75.27.

Insider Activity

In other Ryan Specialty news, Director Nicholas Dominic Cortezi sold 10,485 shares of Ryan Specialty stock in a transaction on Thursday, January 23rd. The shares were sold at an average price of $65.12, for a total transaction of $682,783.20. Following the sale, the director now owns 11,109 shares of the company’s stock, valued at $723,418.08. The trade was a 48.56 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP Brendan Martin Mulshine sold 30,000 shares of Ryan Specialty stock in a transaction on Friday, March 14th. The stock was sold at an average price of $69.30, for a total value of $2,079,000.00. The disclosure for this sale can be found here. Insiders have sold 241,360 shares of company stock valued at $16,006,428 over the last ninety days. 11.10% of the stock is currently owned by insiders.

Ryan Specialty Price Performance

RYAN stock opened at $70.55 on Friday. Ryan Specialty Holdings, Inc. has a 12 month low of $48.48 and a 12 month high of $77.16. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The stock has a market cap of $18.48 billion, a PE ratio of 102.25, a P/E/G ratio of 1.19 and a beta of 0.66. The company has a 50-day moving average price of $69.60 and a 200 day moving average price of $68.64.

Ryan Specialty (NYSE:RYAN) last released its quarterly earnings data on Thursday, February 20th. The company reported $0.45 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.02). The business had revenue of $663.53 million during the quarter, compared to analysts’ expectations of $658.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. Equities research analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were paid a $0.12 dividend. The ex-dividend date of this dividend was Tuesday, March 4th. This is a boost from Ryan Specialty’s previous quarterly dividend of $0.11. This represents a $0.48 dividend on an annualized basis and a yield of 0.68%. Ryan Specialty’s dividend payout ratio (DPR) is 69.57%.

About Ryan Specialty

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.